Biopharmaceutical CMO And CRO Market Size, Share & Trends Report

Biopharmaceutical CMO And CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product, And Segment Forecasts, 2024 - 2030

Report ID: GVR-1-68038-500-7
Number of Pages: 180
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Market Segmentation

Biopharmaceutical CMO & CRO Source Outlook (Revenue, USD Billion, 2018 - 2030)
- Mammalian
- Non-mammalian
Biopharmaceutical CMO & CRO Service Outlook (Revenue, USD Billion, 2018 - 2030)
- Contract Manufacturing
  - Process Development
    - Downstream
    - Upstream
    - Fill & Finish Operations
    - Analytical & QC studies
    - Packaging
- Contract Research
  - Oncology
  - Inflammation & Immunology
  - Cardiology
  - Neuroscience
  - Others
Biopharmaceutical CMO & CRO Product Outlook (Revenue, USD Billion, 2018 - 2030)
- Biologics
  - Monoclonal antibodies (MAbs)
  - Recombinant Proteins
  - Vaccines
  - Antisense, RNAi, & Molecular Therapy
  - Others
- Biosimilars
Biopharmaceutical CMO & CRO Market: Regional Outlook (Revenue, USD Billion, 2018- 2030)
- North America
  - North America Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
    - Mammalian
    - Non-mammalian
  - North America Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
    - Contract Manufacturing
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Contract Research
      - Oncology
      - Inflammation & Immunology
      - Cardiology
      - Neuroscience
      - Others
  - North America Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
    - Biologics
      - Monoclonal antibodies (MAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Biosimilars
  - U.S.
    - U.S. Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - U.S. Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - U.S. Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Canada
    - Canada Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Canada Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Canada Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
- Europe
  - Europe Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
    - Mammalian
    - Non-mammalian
  - Europe Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
    - Contract Manufacturing
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Contract Research
      - Oncology
      - Inflammation & Immunology
      - Cardiology
      - Neuroscience
      - Others
  - Europe Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
    - Biologics
      - Monoclonal antibodies (MAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Biosimilars
  - U.K.
    - U.K.Biopharm aceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - U.K. Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - U.K. Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Germany
    - Germany Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Germany Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Germany Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - France
    - France Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - France Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - France Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Italy
    - Italy Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Italy Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Italy Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Spain
    - Spain Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Spain Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Spain Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Sweden
    - Sweden Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Sweden Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Sweden Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Norway
    - Norway Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Norway Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Norway Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Denmark
    - Denmark Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Denmark Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Denmark Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
- Asia Pacific
  - Asia Pacific Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
    - Mammalian
    - Non-mammalian
  - Asia Pacific Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
    - Contract Manufacturing
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Contract Research
      - Oncology
      - Inflammation & Immunology
      - Cardiology
      - Neuroscience
      - Others
  - Asia Pacific Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
    - Biologics
      - Monoclonal antibodies (MAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Biosimilars
  - Japan
    - Japan Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Japan Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Japan Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - China
    - China Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - China Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - China Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - India
    - India Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - India Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - India Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - South Korea
    - South Korea Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - South Korea Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - South Korea Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Australia
    - Australia Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Australia Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Australia Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Thailand
    - Thailand Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Thailand Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Thailand Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
- Latin America
  - Latin America Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
    - Mammalian
    - Non-mammalian
  - Latin America Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
    - Contract Manufacturing
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Contract Research
      - Oncology
      - Inflammation & Immunology
      - Cardiology
      - Neuroscience
      - Others
  - Latin America Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
    - Biologics
      - Monoclonal antibodies (MAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Biosimilars
  - Brazil
    - Brazil Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Brazil Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Brazil Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Mexico
    - Mexico Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Mexico Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Mexico Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Argentina
    - Argentina Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Argentina Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Argentina Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
- Middle East & Africa
  - Middle East & Africa Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
    - Mammalian
    - Non-mammalian
  - Middle East & Africa Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
    - Contract Manufacturing
      - Process Development
        
        Downstream
        
        Upstream
      - Fill & Finish Operations
      - Analytical & QC studies
      - Packaging
    - Contract Research
      - Oncology
      - Inflammation & Immunology
      - Cardiology
      - Neuroscience
      - Others
  - Middle East & Africa Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
    - Biologics
      - Monoclonal antibodies (MAbs)
      - Recombinant Proteins
      - Vaccines
      - Antisense, RNAi, & Molecular Therapy
      - Others
    - Biosimilars
  - South Africa
    - South Africa Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - South Africa Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - South Africa Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Saudi Arabia
    - Saudi Arabia Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Saudi Arabia Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Saudi Arabia Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - UAE
    - UAE Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - UAE Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - UAE Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars
  - Kuwait
    - Kuwait Biopharmaceutical CMO & CRO Market, By Source, 2018- 2030 (USD Billion)
      - Mammalian
      - Non-mammalian
    - Kuwait Biopharmaceutical CMO & CRO Market, By Service, 2018- 2030 (USD Billion)
      - Contract Manufacturing
        
        Process Development
        
        Downstream
        
        Upstream
        
        Fill & Finish Operations
        
        Analytical & QC studies
        
        Packaging
      - Contract Research
        
        Oncology
        
        Inflammation & Immunology
        
        Cardiology
        
        Neuroscience
        
        Others
    - Kuwait Biopharmaceutical CMO & CRO Market, By Products, 2018- 2030 (USD Billion)
      - Biologics
        
        Monoclonal antibodies (MAbs)
        
        Recombinant Proteins
        
        Vaccines
        
        Antisense, RNAi, & Molecular Therapy
        
        Others
      - Biosimilars

Biopharmaceutical CMO And CRO Market Dynamics

Driver: Rising investments for capacity expansion by CMOs

With improvements in outsourcing services, the biopharmaceutical industry continues to show surge in number of biopharmaceutical firms opting for contract services. CMOs are making enormous investments for expanding their manufacturing capabilities. For instance, in March 2022, Cambrex, a U.S.-based CDMO, expanded its biopharmaceutical testing services business with the addition of 11 cGMP laboratories in its U.S. facility. This expansion included the addition of instruments for nanoparticle size analysis, qPCR, imaging, immunoblotting, mass spectrometry, next-generation sequencing, and other applications. In another development, in February 2022, Piramal Pharma, an Indian CDMO announced an investment of USD 74.4 million to expand its active pharmaceutical ingredient and antibody-drug conjugate (ADC) manufacturing facilities in the UK. Smaller companies are also expanding their manufacturing facilities. For instance, in April 2019, Lithuania-based Biotechpharma UAB expanded its facility in the country with the addition of a new line of bioreactors with 5,000 liters capacity. Many entities are also observed to add capacity through both internal expansions and acquisitions to address the rising demand for such services. For instance, in February 2022, Recipharm acquired Arranta Bio, a provider of advanced therapy medicinal products, to expand its biologics offerings in the U.S. Such actions by market players are expected to promote market growth.

Driver: Commercial success and consequent strong demand for biopharmaceuticals

Biopharmaceuticals manufacturing is recognized as a leading sector in terms of growth potential. Many healthcare entities believe that this sector would be one of the top 10 revenue generators in the coming years. Moreover, market players are making continuous efforts for developing this sector to meet the increasing demand for bio-based pharmaceuticals, which is expected to boost the number of CMOs/CROs for biopharmaceutical production. This growth of biopharmaceuticals has resulted in the development of a large product pipeline. By understanding the cost-effectiveness due to contract manufacturing, many firms have begun to outsource parts of their biopharmaceutical manufacturing to contract manufacturers. In 2019, the FDA approved 36 biopharmaceutical products, including recombinant proteins, monoclonal antibodies, and others. According to the International Federation of Pharmaceutical Manufacturers & Associations, biopharmaceutical R&D spending generated USD 179 million in 2018 and this number is expected to grow to USD 213 million by 2025, owing to the rising demand for biopharmaceuticals. The number of pipeline drugs have significantly increased in recent years. As per Pharma Intelligence, in 2018, 15,267 drugs were in the pipeline and in 2021, 18,582 drugs were in the pipeline. This is expected to drive the growth of the market. The biologics industry has grown substantially in recent years to include novel product types including rDNA, nanobodies, synthetic vaccines, soluble receptors, fusion proteins, immunoconjugates, and immunotherapeutics. Because of revolutionization of disease therapy through biologics, this sector provides many opportunities to explore hybrid structures that combine biologics with well-defined chemical entities.

Restraint: Limited outsourcing among major biopharmaceutical manufacturers

Presence of well-established international players in the market, which are capable of performing in-house production, is expected to hamper growth of the market to a certain extent. Several big pharma clients are involved in conducting in-house R&D and clinical drug testing through a well-established infrastructure. Large firms consider outsourcing perilous due to loss of strategic control and limited management oversight. Owing to this, large pharma companies opt to maintain their manufacturing operations in-house. Furthermore, firms are using their in-house capabilities as a strategy to maintain secrecy of their product development processes. Owing to these factors, several biopharmaceutical entities have chosen to maintain in-house biologics development. For instance, in March 2022, IASO Biotherapeutics, a biopharmaceutical company involved in the manufacturing of drugs, stated that it had received a drug manufacturing license by the Medical Products Administration of Province Jiangsu to produce CAR-T Cell Therapy Products. Big pharma companies are investing significant amounts in their in-house manufacturing facilities, which is, consequently, anticipated to impede market growth.

What Does This Report Include?

This section will provide insights into the contents included in this biopharmaceutical CMO and CRO market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Biopharmaceutical CMO And CRO market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Biopharmaceutical CMO And CRO market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.